IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,791,816 | +74.3% | 61,548 | +57.6% | 0.02% | +57.1% |
| Q2 2023 | $1,601,975 | +6.2% | 39,044 | -7.5% | 0.01% | 0.0% |
| Q1 2023 | $1,508,549 | -85.0% | 42,209 | -84.1% | 0.01% | -83.3% |
| Q4 2022 | $10,039,190 | +9.3% | 265,798 | +28.0% | 0.08% | +9.1% |
| Q3 2022 | $9,185,000 | +90.8% | 207,672 | +59.7% | 0.08% | +63.8% |
| Q2 2022 | $4,813,000 | +134.0% | 130,023 | +134.1% | 0.05% | +147.4% |
| Q1 2022 | $2,057,000 | +117.0% | 55,543 | +163.2% | 0.02% | +58.3% |
| Q1 2021 | $948,000 | +10.9% | 21,101 | +39.4% | 0.01% | +9.1% |
| Q4 2020 | $855,000 | +45.4% | 15,135 | +21.7% | 0.01% | -70.3% |
| Q1 2020 | $588,000 | +40.3% | 12,436 | +19.2% | 0.04% | -11.9% |
| Q1 2017 | $419,000 | -56.2% | 10,431 | -47.8% | 0.04% | -66.1% |
| Q4 2016 | $957,000 | +170.3% | 20,000 | +129.1% | 0.12% | -13.9% |
| Q1 2016 | $354,000 | – | 8,731 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |